Effects of co-administration of avagacestat and clopidogrel on the pharmacokinetics of clopidogrel in volunteers

Trial Profile

Effects of co-administration of avagacestat and clopidogrel on the pharmacokinetics of clopidogrel in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2012

At a glance

  • Drugs Avagacestat (Primary) ; Clopidogrel (Primary)
  • Indications Alzheimer's disease; Cardiovascular disorders; Embolism and thrombosis
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 04 Aug 2012 New trial record
    • 19 Jul 2012 Results presented at the 2012 International Conference on Alzheimer's Disease.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top